Pant, S., Burris, H. A., Moore, K., Bendell, J. C., Kurkjian, C., Jones, S. F., . . . Infante, J. R. (2013). A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors. Springer US.
Styl cytowania ChicagoPant, Shubham, et al. A First-in-human Dose-escalation Study of ME-143, a Second Generation NADH Oxidase Inhibitor, in Patients With Advanced Solid Tumors. Springer US, 2013.
Styl cytowania MLAPant, Shubham, et al. A First-in-human Dose-escalation Study of ME-143, a Second Generation NADH Oxidase Inhibitor, in Patients With Advanced Solid Tumors. Springer US, 2013.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..